A large language model (LLM)-based multi-agent framework for risk stratification and treatment recommendations in localized prostate cancer (locPCa).
5108 Background: We previously proposed a hybrid framework combining LLMs and rule based algorithm (RBA) for automating risk stratification in locPCa. Herein, we aim to validate the risk stratification agent (RSA) in a prospective cohort, develop & evaluate the treatment recommendation agent (TRA) based on NCCN guidelines, and develop an interactive interface to facilitate clinicians for accurate risk stratification and treatment recommendations at the point of care. Methods: This study included pts with locPCa (2004-2024) presenting at Mayo Clinic with at least 1 positive prostate biopsy and MRI report available. For RSA prospective validation, GPT4 extracted key phenotypic variables (PSA, T stage, prostate volume, number of cores, Gleason patterns, grade group) from unstructured MRI and biopsy reports using a zeroshot prompt. An RBA then classified pts into NCCN risk groups. The agent performance was compared with the treating clinician's documentation and evaluated against gold-standard labels manually annotated by two independent clinicians. For development of TRA, two experiments were performed using GPT4 with and without retrieval-augmented generation (RAG) to generate treatment plans. Generated treatment plans were evaluated using NCCN guideline-informed treatment decision tree based algorithm (DTA). Evaluation metrics, weighted – accuracy (acc) and F1, were computed. A clinician facing interface (lisr.org/risk) was developed to provide accurate risk stratification and treatment plans. Results: A total of 858 pts were included (500 for prospective validation, 358 for treatment recommendations). Prospective validation for RSA demonstrated a higher F1 score of 0.89 compared to the treating clinician (F1: 0.58). Treatment recommendation experiments showed that GPT4 with RAG achieved higher acc (64% full – all correct treatment options and 36% partial – at least 1 correct treatment option) compared to GPT4 alone (35% and 65%, respectively). Sensitivity analysis using DTA-informed GPT4 note generation achieved 94% full acc and 6% partial acc. GPT4 alone generated hallucinated treatment options in 71% of cases, while GPT4 with RAG reduced this to 32%. Conclusions: The multi-agent framework based on LLM and RBA achieves high accuracy in risk stratification and treatment recommendation for locPCa. A multi-agent framework with an interactive interface holds high promise to enable efficient, accurate decision-making, and improve locPCa management at the point of care Performance evaluation. RSA(acc; F1) % TRA(full acc; partial acc) % Clinician RSA* GPT4 RAG+GPT4 DTA+GPT4 Overall 60; 58 89; 89 29; 71 64; 36 94; 6 V. High 94; 33 96; 96 55; 45 69; 31 93; 7 High 46; 52 92; 89 - - - Int. Unf 80; 61 91; 90 5; 95 38; 62 93; 7 Int. Fav 57; 64 84; 87 0; 100 98; 2 100; 0 Low 57; 65 87; 80 100; 0 95; 5 90; 10 V. Low 8; 13 50; 67^ - - - *Statistical significance (p<0.01) except for ^V. Low.
Authors
- Mark Raymond Waddle (ORCID: https://orcid.org/0000-0002-6017-8850)
- Daniel M. Frendl (ORCID: https://orcid.org/0000-0002-3571-6610)
- Umair Ayub (ORCID: https://orcid.org/0000-0001-8961-3978)
- Daniel S. Childs (ORCID: https://orcid.org/0000-0001-7643-2836)
- Irbaz Bin Riaz (ORCID: https://orcid.org/0000-0003-4249-0311)
- Alan Haruo Bryce (ORCID: https://orcid.org/0000-0002-0206-3895)
- Muhammad Afzal (ORCID: https://orcid.org/0000-0002-5785-6067)
- Sumanta Kumar Pal (ORCID: https://orcid.org/0000-0002-1712-0848)
- Kaneez Zahra Rubab Khakwani
- Yousef Zakharia (ORCID: https://orcid.org/0000-0001-9480-2626)
- Syed Arsalan Ahmed Naqvi (ORCID: https://orcid.org/0000-0002-3131-2088)
- Parminder Singh (ORCID: https://orcid.org/0000-0002-2851-6805)
- Chitta Baral (ORCID: https://orcid.org/0000-0002-7549-723X)
- Abhishek Tripathi (ORCID: https://orcid.org/0000-0002-5198-0673)
- Haidar Abdul‐Muhsin (ORCID: https://orcid.org/0000-0001-9850-428X)
- Salman Ayub Jajja
- Neeraj Agarwal (ORCID: https://orcid.org/0000-0003-1076-0428)
- Ji-Eun Irene Yum
- Jack Andrews
Institutions
- Mayo Clinic (US)
- University of Arizona (US)
- University of Utah (US)
- Huntsman Cancer Institute (US)
- City of Hope (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- University of Oklahoma Health Sciences Center (US)
- Arizona State University (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1200/jco.2025.43.16_suppl.5108
- Citations
- 3
- Primary Topic
- Topic Modeling
- Type
- article
- Field-Weighted Citation Impact
- 7.44